Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients

Mara A. McAdams-Demarco, Elizabeth A. King, Xun Luo, Christine Haugen, Sandra Dibrito, Ashton Shaffer, Lauren M. Kucirka, Niraj M. Desai, Nabil N Dagher, Bonnie Lonze, Robert Avery Montgomery, Jeremy Walston, Dorry L. Segev

Research output: Contribution to journalArticlepeer-review

64 Scopus citations


Objective: To test whether frailty, a novel measure of physiologic reserve, is associated with longer kidney transplant (KT) length of stay (LOS), and modifies the association between LOS and mortality. Background: Better understanding of LOS is necessary for informed consent and discharge planning. Mortality resulting from longer LOS has important regulatory implications for hospital and transplant programs. Which recipients are at risk of prolonged LOS and its effect on mortality are unclear. Frailty is a novel preoperative predictor of poor KT outcomes including delayed graft function, early hospital readmission, immunosuppression intolerance, and mortality. Methods: We used registry-augmented hybrid methods, a novel approach to risk adjustment, to adjust for LOS risk factors from the Scientific Registry of Transplant Recipients (n = 74,859) and tested whether (1) frailty, measured immediately before KT in a novel cohort (n = 589), was associated with LOS (LOS: negative binomial regression; LOS ≥2 weeks: logistic regression) and (2) whether frailty modified the association between LOS and mortality (interaction term analysis). Results: Frailty was independently associated with longer LOS [relative risk = 1.15, 95% confidence interval (CI): 1.03-1.29; P = 0.01] and LOS ≥2 weeks (odds ratio = 1.57, 95% CI: 1.06-2.33; P = 0.03) after accounting for registry-based risk factors, including delayed graft function. Frailty also attenuated the association between LOS and mortality (nonfrail hazard rate = 1.55 95% CI: 1.30-1.86; P < 0.001; frail hazard rate = 0.97, 95% CI: 0.79-1.19, P = 0.80; P for interaction = 0.001). Conclusions: Frail KT recipients are more likely to experience a longer LOS. Longer LOS among nonfrail recipients may be a marker of increased mortality risk. Frailty is a measure of physiologic reserve that may be an important clinical marker of longer surgical LOS.

Original languageEnglish (US)
Pages (from-to)1084-1090
Number of pages7
JournalAnnals of surgery
Issue number6
StatePublished - Dec 1 2017


  • frailty
  • kidney transplantation
  • length of stay
  • mortality

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients'. Together they form a unique fingerprint.

Cite this